“Do you have PCOS?”
“Oh… so it might be difficult for you to conceive?”
For years, conversations around PCOS have been painfully narrow, reducing an incredibly complex condition to fertility alone. But women living with it know the truth: PCOS affects far more than just the ovaries.
And now, that reality is finally being acknowledged.
The proposed shift from PCOS to PMOS isn’t just a medical rename. For many, it feels like validation. Let’s dive deep and explore why the name change occurred and how it has changed people’s perspective towards the disease.
The Problem With the Name PCOS
Polycystic Ovary Syndrome (PCOS), as the name suggests, indicates the presence of multiple cysts in the ovaries. These tiny “cysts” are actually immature ovarian follicles (that house an ovum). They never grow large enough to trigger ovulation due to a hormonal imbalance. As a result, ovulation becomes irregular or absent, leading to irregular menstrual cycles and reduced chances of natural conception.
At the cellular level, the outer layer of the ovarian follicle contains specialized cells called theca cells, which naturally produce androgens. In women with PCOS, genetic factors and abnormal hormonal signaling from the pituitary gland can make these theca cells hyperactive. As a result, they produce far more androgens than the ovaries normally require. This hormonal imbalance disrupts normal follicle development, causing the accumulation of multiple immature follicles in the ovaries.
But this is exactly where the problem with the name begins.
For years, PCOS has largely been reduced to a “fertility condition,” when in reality, its effects extend far beyond the ovaries. Yes, infertility can be a major challenge for many women with PCOS, but the condition is much more complex than reproduction alone.
PCOS was never just about the ovaries
PCOS is deeply linked to hormonal and metabolic dysfunction. Many women experience insulin resistance, which can lead to intense sugar cravings, difficulty losing weight, and an increased risk of metabolic disorders. Elevated androgen levels, such as those found in male hormones like testosterone, can result in acne, excessive facial hair growth, and scalp hair thinning.
And the impact is not only physical.
Living with a chronic hormonal imbalance can also affect mental health. Mood swings, anxiety, low self-esteem, body image issues, and even depression are commonly reported by women with PCOS.
This is why many experts and many women living with the condition believe the term PCOS no longer reflects the true nature of the disorder.
Why Experts Proposed the Name PMOS
In May 2026, Polycystic Ovary Syndrome (PCOS) was officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) following a global medical consensus published in The Lancet. The decision came after years of growing concern that the term “PCOS” was scientifically inaccurate and emotionally misleading.
One of the biggest problems was the word “cysts.” The fluid-filled structures seen in PCOS are not dangerous pathological cysts, but immature ovarian follicles that failed to develop properly. Yet for years, the name caused unnecessary fear, leaving many women worried that they had abnormal growths that could rupture or require surgery.
The Danger of Reducing PCOS to Fertility Alone
Ironically, many women were also denied a diagnosis because doctors did not see “cysts” on an ultrasound scan — even though polycystic ovaries are not required for diagnosis. As a result, countless women spent years struggling with untreated metabolic and hormonal symptoms simply because the condition’s name pointed clinicians in the wrong direction.
The older term also framed the disorder mainly as a gynecological or fertility issue, when the condition clearly affects multiple systems throughout the body. The updated name, PMOS, was designed to reflect that broader reality.
Polyendocrine
This acknowledges that multiple hormone systems are disrupted, including insulin, cortisol, reproductive hormones, and androgens.
Metabolic
This highlights the strong connection to insulin resistance, weight changes, cardiovascular risk, and Type 2 diabetes.
Ovarian Syndrome
This retains the reproductive aspect of the condition, including irregular ovulation and menstrual cycle disturbances, without relying on misleading terminology.
Is PMOS Official Yet?
A three-year global transition period is now underway to gradually phase out the term PCOS. For now, the diagnostic criteria, medications, and overall treatment approaches remain largely unchanged. However, experts believe this renaming could reshape the way the condition is viewed by doctors, researchers, healthcare systems, and insurance providers.
More Than a Name Change, It’s Validation
For many women, this name is not just about medical terminology. It feels deeply personal.
For years, people living with PCOS have struggled to explain that the condition was never “just about periods” or “just about fertility.” They carried the weight of unexplained fatigue, stubborn weight gain, acne, anxiety, mood swings, body image issues, insulin resistance, and the constant feeling that their symptoms were being minimized because the condition sounded limited to the ovaries.
And sometimes, the hardest part was not the symptoms themselves but not feeling fully understood.
The shift from PCOS to PMOS acknowledges what millions of women have been saying for years: this is a whole-body condition. A hormonal condition. A metabolic condition. A mental health burden. Not simply a reproductive issue.
That is why so many women felt emotional, relieved, and even “seen” when the name changed.
Because words matter in medicine. A name shapes conversations, diagnoses, research priorities, treatment approaches, and even the way patients see themselves. And perhaps for the first time, the name finally reflects the reality they have been living all along.
Thanks for sharing